Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography
- PMID: 7501148
- DOI: 10.1212/wnl.45.11.1995
Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography
Abstract
Early-stage Parkinson's disease (EPD) is often clinically asymmetric. We used 18F-fluorodeoxyglucose (FDG) and PET to assess whether EPD can be detected by a characteristic pattern of regional metabolic asymmetry. To identify this pattern, we studied 10 EPD (Hoehn and Yahr stage I) patients (mean age 61.1 +/- 11.1 years) using 18F-FDG and PET to calculate regional metabolic rates for glucose. The scaled subprofile model (SSM) was applied to metabolic asymmetry measurements for the combined group of EPD patients and normal subjects to identify a specific covariation pattern that discriminated EPD patients from normal subjects. To determine whether this pattern could be used diagnostically, we studied a subsequent group of five presumptive EPD patients (mean age 50.9 +/- 18.3), five normal subjects (mean age 44.6 +/- 15.3), and nine patients with atypical drug-resistant early-stage parkinsonism (APD) (mean age 44.6 +/- 14.0). In each member of this prospective cohort, we calculated the expression of the EPD-related covariation pattern (subject scores) on a case-by-case basis. We also studied 11 of the EPD patients, five patients with APD, and 10 normal subjects with 18F-fluorodopa (FDOPA) and PET to measure presynaptic nigrostriatal dopaminergic function, and we assessed the accuracy of differential diagnosis with both PET methods using discrimination analysis. SSM analysis disclosed a significant topographic contrast profile characterized by covariate basal ganglia and thalamic asymmetries. Subject scores for this profile accurately discriminated EPD patients from normal subjects and APD patients (p < 0.0001). Group assignments into the normal or parkinsonian categories with FDG/PET were comparable to those achieved with FDOPA/PET, although APD and EPD patients were not differentiable by the latter method. Metabolic brain imaging with FDG/PET may be useful in the differential diagnosis of EPD.
Similar articles
-
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.Mov Disord. 1990;5(3):203-13. doi: 10.1002/mds.870050304. Mov Disord. 1990. PMID: 2117706
-
The metabolic topography of normal aging.J Cereb Blood Flow Metab. 1996 May;16(3):385-98. doi: 10.1097/00004647-199605000-00005. J Cereb Blood Flow Metab. 1996. PMID: 8621743
-
[18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].Nihon Rinsho. 1997 Jan;55(1):222-6. Nihon Rinsho. 1997. PMID: 9014454 Review. Japanese.
-
Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.J Nucl Med. 1995 Mar;36(3):378-83. J Nucl Med. 1995. PMID: 7884498
-
[Functional imaging for disorders of basal ganglia].Rinsho Shinkeigaku. 1999 Jan;39(1):30-2. Rinsho Shinkeigaku. 1999. PMID: 10377793 Review. Japanese.
Cited by
-
Age-Related Regional Network Covariance of Magnetic Resonance Imaging Gray Matter in the Rat.Front Aging Neurosci. 2020 Aug 26;12:267. doi: 10.3389/fnagi.2020.00267. eCollection 2020. Front Aging Neurosci. 2020. PMID: 33005147 Free PMC article.
-
Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease.Mov Disord. 2009;24 Suppl 2(0 2):S725-31. doi: 10.1002/mds.22541. Mov Disord. 2009. PMID: 19877247 Free PMC article. Review.
-
Correlation of Parkinson's disease severity and 18F-FDG and 18F-FP-DTBZ PET.Quant Imaging Med Surg. 2025 Apr 1;15(4):3036-3047. doi: 10.21037/qims-24-2047. Epub 2025 Mar 28. Quant Imaging Med Surg. 2025. PMID: 40235814 Free PMC article.
-
Neuroimaging in Parkinson disease: from research setting to clinical practice.Nat Rev Neurol. 2014 Dec;10(12):708-22. doi: 10.1038/nrneurol.2014.205. Epub 2014 Nov 11. Nat Rev Neurol. 2014. PMID: 25385334 Review.
-
Functional neuroimaging in Parkinson's disease.Cold Spring Harb Perspect Med. 2012 May;2(5):a009274. doi: 10.1101/cshperspect.a009274. Cold Spring Harb Perspect Med. 2012. PMID: 22553499 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical